Jazz Pharmaceuticals (JAZZ) Tax Rate Growth (1y) (2013 - 2026)

Jazz Pharmaceuticals (JAZZ) Tax Rate Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Jazz Pharmaceuticals 15.75 Bn 13.91 Bn 934.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,417.00
Dec 31, 2025 4,586.00
Sep 30, 2025 -267,566.00
Jun 30, 2025 2,460.00
Mar 31, 2025 74,461.00
Dec 31, 2024 1,031.00
Sep 30, 2024 4,019.00
Jun 30, 2024 745.00
Mar 31, 2024 -70,059.00
Dec 31, 2023 -8,322.00
Sep 30, 2023 -11,894.00
Jun 30, 2023 4,690.00
Mar 31, 2023 -3,629.00
Dec 31, 2022 162.00
Sep 30, 2022 4,475.00
Jun 30, 2022 9,140.00
Mar 31, 2022 -479.00
Dec 31, 2021 2,042.00
Sep 30, 2021 1,528.00
Jun 30, 2021 -19,995.00